Skip to main content
Loading market data...
ETF NYSE Arca USD

ROBO Global Healthcare Technology and Innovation ETF HTEC

Issuer: not identified from the fund name SEC registrant: EXCHANGE TRADED CONCEPTS TRUST Equity · Global
Last price 44.02 USD Change: Up +1.09 Percent change: Up +2.54%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Net expense ratio
0.68%
Prospectus 28 Aug 2025
Net assets
$69.1M
As of 31 Jul 2026
Holdings
63
As of 31 Jul 2026
12-month distribution yield
0.79%
Irregular
Asset class
Equity
From holdings

ROBO Global Healthcare Technology and Innovation ETF (HTEC) is an exchange-traded fund listed on NYSE Arca in the United States. Its category is Equity · Global (equity). Its last price was US$44.02 on 20 Oct 2026. Its net expense ratio is 0.68% a year, from its prospectus dated 28 Aug 2025. It reported net assets of US$69.12 million as of 31 Jul 2026. Its latest holdings report lists 63 holdings as of 31 Jul 2026. Over the last 12 months it paid distributions of US$0.35 a unit, a 12-month distribution yield of 0.79%.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.80%
Net, after fee waivers or reimbursements
0.68%
Management fee
0.80%
Prospectus date
28 Aug 2025
Filed with the SEC
26 Aug 2025

Size and reporting

Net assets
$69,122,543
Total assets
$69,162,752
Holdings as of
31 Jul 2026
Report made public
28 Sep 2026 (59 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 63 positions, as of 31 Jul 2026. Weight is the percent of net assets the fund reported.

HTEC top holdings as of 31 Jul 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 CAREDX, INC. CAREDX INC COMMON STOCK US14167L1035 2.68% $1.9M Equity (common) United States USD
2 GUARDANT HEALTH, INC. GUARDANT HEALTH INC COMMON STOCK US40131M1099 2.31% $1.6M Equity (common) United States USD
3 NATERA, INC. NATERA INC COMMON STOCK US6323071042 2.23% $1.5M Equity (common) United States USD
4 Twist Bioscience Corp TWIST BIOSCIENCE CORP COMMON STOCK US90184D1000 2.23% $1.5M Equity (common) United States USD
5 THERMO FISHER SCIENTIFIC INCORPORATED THERMO FISHER SCIENTIFIC INC COMMON STOCK US8835561023 2.18% $1.5M Equity (common) United States USD
6 MEDPACE HOLDINGS, INC. MEDPACE HOLDINGS INC COMMON STOCK US58506Q1094 2.12% $1.5M Equity (common) United States USD
7 ADAPTIVE BIOTECHNOLOGIES CORPORATION ADAPTIVE BIOTECHNOLOGIES COMMON STOCK US00650F1093 2.11% $1.5M Equity (common) United States USD
8 IQVIA HOLDINGS INC IQVIA HOLDINGS INC COMMON STOCK US46266C1053 2.10% $1.5M Equity (common) United States USD
9 ILLUMINA, INC. ILLUMINA INC COMMON STOCK US4523271090 2.09% $1.4M Equity (common) United States USD
10 ARROWHEAD PHARMACEUTICALS, INC. ARROWHEAD PHARMACEUTICALS IN COMMON STOCK US04280A1007 2.08% $1.4M Equity (common) United States USD
11 REGENERON PHARMACEUTICALS, INC. REGENERON PHARMACEUTICALS COMMON STOCK US75886F1075 1.97% $1.4M Equity (common) United States USD
12 GLAUKOS CORPORATION GLAUKOS CORP COMMON STOCK US3773221029 1.92% $1.3M Equity (common) United States USD
13 VERTEX PHARMACEUTICALS INCORPORATED VERTEX PHARMACEUTICALS INC COMMON STOCK US92532F1003 1.91% $1.3M Equity (common) United States USD
14 STRYKER CORPORATION STRYKER CORP COMMON STOCK US8636671013 1.91% $1.3M Equity (common) United States USD
15 LIVANOVA PLC LIVANOVA PLC COMMON STOCK GB00BYMT0J19 1.87% $1.3M Equity (common) United States USD
16 Siemens Healthineers AG SIEMENS HEALTHINEERS AG COMMON STOCK DE000SHL1006 1.85% $1.3M Equity (common) Germany EUR
17 Lonza Group AG LONZA GROUP AG-REG COMMON STOCK CH0013841017 1.85% $1.3M Equity (common) Switzerland CHF
18 INCYTE CORPORATION INCYTE CORP COMMON STOCK US45337C1027 1.80% $1.2M Equity (common) United States USD
19 ABBOTT LABORATORIES ABBOTT LABORATORIES COMMON STOCK US0028241000 1.79% $1.2M Equity (common) United States USD
20 AxoGen, Inc. AXOGEN INC COMMON STOCK US05463X1063 1.77% $1.2M Equity (common) United States USD
21 BOSTON SCIENTIFIC CORPORATION BOSTON SCIENTIFIC CORP COMMON STOCK US1011371077 1.73% $1.2M Equity (common) United States USD
22 Grail Inc GRAIL INC COMMON STOCK US3847471014 1.72% $1.2M Equity (common) United States USD
23 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CHARLES RIVER LABORATORIES COMMON STOCK US1598641074 1.71% $1.2M Equity (common) United States USD
24 DANAHER CORPORATION DANAHER CORP COMMON STOCK US2358511028 1.67% $1.2M Equity (common) United States USD
25 Tecan Group AG TECAN GROUP AG-REG COMMON STOCK CH0012100191 1.66% $1.1M Equity (common) Switzerland CHF

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.81%
Short-term investment vehicles (cash funds) 0.16%

Country

Country by weight
CountryWeightBar
United States 82.89%
Switzerland 4.97%
Hong Kong 3.69%
Germany 1.85%
Netherlands 1.62%
France 1.59%
Italy 1.26%
United Kingdom 1.08%
Japan 1.01%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 82.89%
Euro (EUR) 6.32%
Swiss franc (CHF) 4.97%
Hong Kong dollar (HKD) 3.69%
British pound (GBP) 1.08%
Japanese yen (JPY) 1.01%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 51.31%
Industrials 7.91%
Technology 2.85%
Miscellaneous 1.33%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.3460
1 payment per unit
12-month yield
0.79%
Distributions only, not total return
Frequency
Irregular
From the gaps between ex-dates
Latest ex-date
30 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.3460) ÷ latest price ($44.02) × 100 = 0.79%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (2 payments)
HTEC distributions per unit by ex-date
Ex-dateAmount per unit
30 Dec 2025$0.3460
28 Dec 2021$0.0230

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme